3,914 Shares in GE HealthCare Technologies Inc. (NASDAQ:GEHC) Bought by Union Bancaire Privee UBP SA

Union Bancaire Privee UBP SA purchased a new position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 3,914 shares of the company's stock, valued at approximately $280,000.

Several other hedge funds also recently bought and sold shares of GEHC. Quent Capital LLC boosted its stake in shares of GE HealthCare Technologies by 18.4% during the third quarter. Quent Capital LLC now owns 766 shares of the company's stock valued at $72,000 after purchasing an additional 119 shares during the period. Greenleaf Trust boosted its position in GE HealthCare Technologies by 1.7% in the 3rd quarter. Greenleaf Trust now owns 7,619 shares of the company's stock valued at $715,000 after buying an additional 124 shares during the period. Westside Investment Management Inc. grew its stake in GE HealthCare Technologies by 32.0% in the 3rd quarter. Westside Investment Management Inc. now owns 516 shares of the company's stock worth $48,000 after acquiring an additional 125 shares in the last quarter. Quarry LP raised its stake in shares of GE HealthCare Technologies by 28.3% during the second quarter. Quarry LP now owns 594 shares of the company's stock valued at $46,000 after acquiring an additional 131 shares in the last quarter. Finally, Harbour Investments Inc. boosted its holdings in shares of GE HealthCare Technologies by 4.3% in the third quarter. Harbour Investments Inc. now owns 3,164 shares of the company's stock valued at $297,000 after purchasing an additional 131 shares during the period. Institutional investors own 82.06% of the company's stock.

GE HealthCare Technologies Stock Down 1.4 %

Shares of GE HealthCare Technologies stock traded down $1.25 on Friday, reaching $88.30. The stock had a trading volume of 1,775,473 shares, compared to its average volume of 2,532,013. GE HealthCare Technologies Inc. has a 1 year low of $72.52 and a 1 year high of $94.55. The company has a 50 day moving average price of $82.87 and a 200 day moving average price of $85.02. The company has a quick ratio of 0.98, a current ratio of 1.23 and a debt-to-equity ratio of 1.12. The stock has a market capitalization of $40.34 billion, a P/E ratio of 24.26, a P/E/G ratio of 2.90 and a beta of 1.11.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last issued its quarterly earnings results on Wednesday, October 30th. The company reported $1.14 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.06 by $0.08. The business had revenue of $4.86 billion for the quarter, compared to the consensus estimate of $4.87 billion. GE HealthCare Technologies had a return on equity of 25.19% and a net margin of 8.56%. The business's quarterly revenue was up .9% on a year-over-year basis. During the same period in the prior year, the firm posted $0.99 earnings per share. As a group, equities research analysts forecast that GE HealthCare Technologies Inc. will post 4.3 EPS for the current year.

GE HealthCare Technologies Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 14th will be given a dividend of $0.035 per share. This is a positive change from GE HealthCare Technologies's previous quarterly dividend of $0.03. This represents a $0.14 annualized dividend and a yield of 0.16%. The ex-dividend date of this dividend is Tuesday, January 14th. GE HealthCare Technologies's dividend payout ratio is currently 3.85%.

Insider Buying and Selling at GE HealthCare Technologies

In other GE HealthCare Technologies news, CEO Roland Rott sold 3,577 shares of the firm's stock in a transaction on Wednesday, November 6th. The shares were sold at an average price of $86.48, for a total value of $309,338.96. Following the completion of the transaction, the chief executive officer now owns 24,298 shares of the company's stock, valued at approximately $2,101,291.04. This trade represents a 12.83 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. 0.27% of the stock is currently owned by company insiders.

Analyst Ratings Changes

A number of equities research analysts have weighed in on GEHC shares. Jefferies Financial Group raised GE HealthCare Technologies from a "hold" rating to a "buy" rating and lifted their target price for the company from $95.00 to $103.00 in a research report on Wednesday, January 8th. Wells Fargo & Company lifted their price objective on GE HealthCare Technologies from $95.00 to $96.00 and gave the company an "overweight" rating in a report on Thursday, October 31st. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating, nine have issued a buy rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average target price of $96.00.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.